Mitochondrial Dysfunction and Immune Cell Metabolism in Sepsis

키워드

참고문헌 (123)

1. Bone RC, "Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis", Chest, 101, pp.1644~1655 (1992), The ACCP[DOI]
2. Martin GS, "The epidemiology of sepsis in the United States from 1979 through 2000", N Engl J Med, 348, pp.1546~1554 (2003)
3. 박대원, "Epidemiological and Clinical Characteristics of Community- Acquired Severe Sepsis and Septic Shock: A Prospective Observational Study in 12 University Hospitals in Korea", Journal of Korean Medical Science, 27(11), pp.1308~1314 (2012), 대한의학회
4. Angus DC, "Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care", Crit Care Med, 29, pp.1303~1310 (2001)
5. Gaieski DF, "Benchmarking the incidence and mortality of severe sepsis in the United States", Crit Care Med, 41, pp.1167~1174 (2013)
6. Fink MP, "Laboratory models of sepsis and septic shock", J Surg Res, 49, pp.186~196 (1990)
7. Deitch EA, "Animal models of sepsis and shock: a review and lessons learned", Shock, 9, pp.1~11 (1998)
8. O'Reilly M, "Endotoxin, sepsis, and the primrose path", Shock, 12, pp.411~420 (1999)
9. Hotchkiss RS, "Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction", Crit Care Med, 27, pp.1230~1251 (1999)
10. Takasu O, "Mechanisms of cardiac and renal dysfunction in patients dying of sepsis", Am J Respir Crit Care Med, 187, pp.509~517 (2013)
11. Boomer JS, "Immunosuppression in patients who die of sepsis and multiple organ failure", JAMA, 306, pp.2594~2605 (2011)
12. Marshall JC, "Why have clinical trials in sepsis failed?", Trends Mol Med, 20, pp.195~203 (2014)
13. Opal SM, "Effect of eritoran, an antagonist of MD2- TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial", JAMA, 309, pp.1154~1162 (2013)
14. Boekstegers P, "Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: comparison to limited infection and cardiogenic shock", Infection, 19, pp.317~323 (1991)
15. Sair M, "Tissue oxygenation and perfusion in patients with systemic sepsis", Crit Care Med, 29, pp.1343~1349 (2001)
16. Fink MP, "Bench-to-bedside review: cytopathic hypoxia", Crit Care, 6, pp.491~499 (2002)
17. Hotchkiss RS, "The pathophysiology and treatment of sepsis", N Engl J Med, 348, pp.138~150 (2003)
18. Levy E, "Hepatic changes produced by a single dose of endotoxin in the mouse", Electron microscopy. Am J Pathol, 52, pp.477~502 (1968)
19. Träger K, "Metabolic alterations in sepsis and vasoactive drug-related metabolic effects", Curr Opin Crit Care, 9, pp.271~278 (2003)
20. Englert JA, "Metabolism, metabolomics, and nutritional support of patients with sepsis", Clin Chest Med, 37, pp.321~331 (2016)
21. Delano MJ, "Magic bullets and surrogate biomarkers circa 2009", Crit Care Med, 37, pp.1796~1798 (2009)
22. Bosmann M, "The inflammatory response in sepsis", Trends Immunol, 34, pp.129~136 (2013)
23. Medzhitov R, "Innate immunity", N Engl J Med, 343, pp.338~344 (2000)
24. Delano MJ, "The immune system's role in sepsis progression, resolution, and long-term outcome", Immunol Rev, 274, pp.330~353 (2016)
25. Rittirsch D, "Harmful molecular mechanisms in sepsis", Nat Rev Immunol, 8, pp.776~787 (2008)
26. Leentjens J, "Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?", Am J Respir Crit Care Med, 187, pp.1287~1293 (2013)
27. Gentile LF, "Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care", J Trauma Acute Care Surg, 72, pp.1491~1501 (2012)
28. Deutschman CS, "Sepsis: current dogma and new perspectives", Immunity, 40, pp.463~475 (2014)
29. Jansen TC, "Blood lactate monitoring in critically ill patients: a systematic health technology assessment", Crit Care Med, 37, pp.2827~2839 (2009)
30. Levraut J, "Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction", Am J Respir Crit Care Med, 157, pp.1021~1026 (1998)
31. McBride HM, "Mitochondria: more than just a powerhouse", Curr Biol, 16, pp.R551~R560 (2006)
32. Chan DC, "Mitochondria: dynamic organelles in disease, aging, and development", Cell, 125, pp.1241~1252 (2006)
33. Galluzzi L, "Mitochondria: master regulators of danger signalling", Nat Rev Mol Cell Biol, 13, pp.780~788 (2012)
34. Osellame LD, "Cellular and molecular mechanisms of mitochondrial function", Best Pract Res Clin Endocrinol Metab, 26, pp.711~723 (2012)
35. Singer M, "Mitochondrial function in sepsis: acute phase versus multiple organ failure", Crit Care Med, 35(9 Suppl), pp.S441~S448 (2007)
36. Larsen FJ, "Regulation of mitochondrial function and energetics by reactive nitrogen oxides", Free Radic Biol Med, 53, pp.1919~1928 (2012)
37. Haden DW, "Mitochondrial biogenesis restores oxidative metabolism during Staphylococcus aureus sepsis", Am J Respir Crit Care Med, 176, pp.768~777 (2007)
38. Singer M, "The role of mitochondrial dysfunction in sepsis- induced multi-organ failure", Virulence, 5, pp.66~72 (2014)
39. Calvano SE, "Inflamm and Host Response to Injury Large Scale Collab. Res. Program. A network- based analysis of systemic inflammation in humans", Nature, 437, pp.1032~1037 (2005)
40. Carré JE, "Survival in critical illness is associated with early activation of mitochondrial biogenesis", Am J Respir Crit Care Med, 182, pp.745~751 (2010)
41. Mayr FB, "Epidemiology of severe sepsis", Virulence, 5, pp.4~11 (2014)
42. Ferro TN, "Smoking in trauma patients: the effects on the incidence of sepsis, respiratory failure, organ failure, and mortality", J Trauma, 69, pp.308~312 (2010)
43. Huttunen R, "Obesity and smoking are factors associated with poor prognosis in patients with bacteraemia", BMC Infect Dis, 7, pp.13~ (2007)
44. Boulos M, "Impaired mitochondrial function induced by serum from septic shock patients is attenuated by inhibition of nitric oxide synthase and poly(ADP-ribose) synthase", Crit Care Med, 31, pp.353~358 (2003)
45. Brealey D, "Association between mitochondrial dysfunction and severity and outcome of septic shock", Lancet, 360, pp.219~223 (2002)
46. Chen Y, "Roles of transcriptional corepressor RIP140 and coactivator PGC-1alpha in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes", Mol Cell Endocrinol, 362, pp.11~18 (2012)
47. Finck BN, "Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease", Circulation, 115, pp.2540~2548 (2007)
48. Seth A, "The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle", Cell Metab, 6, pp.236~245 (2007)
49. Grégoire M, "HMGB1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock", J Leukoc Biol (2016)
50. Liu Z, "AMP-activated protein kinase and Glycogen Synthase Kinase 3β modulate the severity of sepsis-induced lung injury", Mol Med (2015)
51. Zmijewski JW, "Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury", Am J Physiol Lung Cell Mol Physiol, 296, pp.L624~L634 (2009)
52. Pelekanou A, "Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study", Crit Care, 13, pp.R172~ (2009)
53. Loftus RM, "Immunometabolism: cellular metabolism turns immune regulator", J Biol Chem, 291, pp.1~10 (2016)
54. O'Neill LA, "Immunometabolism governs dendritic cell and macrophage function", J Exp Med, 213, pp.15~23 (2016)
55. Cheng SC, "Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis", Nat Immunol, 17, pp.406~413 (2016)
56. Vats D, "Oxidative metabolism and PGC-1beta attenuate macrophage- mediated inflammation", Cell Metab, 4, pp.13~24 (2006)
57. Link DC, "Neutrophil homeostasis: a new role for stromal cell-derived factor-1", Immunol Res, 32, pp.169~178 (2005)
58. van Raam BJ, "Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation", PLoS One, 3, pp.e2013~ (2008)
59. Borregaard N, "Energy metabolism of human neutrophils during phagocytosis", J Clin Invest, 70, pp.550~557 (1982)
60. Dale DC, "The phagocytes: neutrophils and monocytes", Blood, 112, pp.935~945 (2008)
61. Pearce EL, "Metabolic pathways in immune cell activation and quiescence", Immunity, 38, pp.633~643 (2013)
62. Lu H, "Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis", J Biol Chem, 277, pp.23111~23115 (2002)
63. Sun Q, "Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth", Proc Natl Acad Sci USA, 108, pp.4129~4134 (2011)
64. Cramer T, "HIF-1alpha is essential for myeloid cell-mediated inflammation", Cell, 112, pp.645~657 (2003)
65. Peyssonnaux C, "HIF-1alpha expression regulates the bactericidal capacity of phagocytes", J Clin Invest, 115, pp.1806~1815 (2005)
66. Cheng SC, "mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity", Science, 3445, pp.1250684~ (2014)
67. Desai SP, "Mitochondrial localization and the persistent migration of epithelial cancer cells", Biophys J, 104, pp.2077~2088 (2013)
68. Campello S, "Orchestration of lymphocyte chemotaxis by mitochondrial dynamics", J Exp Med, 203, pp.2879~2886 (2006)
69. Hollenbeck PJ, "The axonal transport of mitochondria", J Cell Sci, 118, pp.5411~5419 (2005)
70. Park DW, "Activation of AMPK enhances neutrophil chemotaxis and bacterial killing", Mol Med, 19, pp.387~398 (2013)
71. Kolaczkowska E, "Neutrophil recruitment and function in health and inflammation", Nat Rev Immunol, 13, pp.159~175 (2013)
72. Zmijewski JW, "Mitochondrial respiratory complex I regulates neutrophil activation and severity of lung injury", Am J Respir Crit Care Med, 178, pp.168~179 (2008)
73. Zmijewski JW, "Antiinflammatory effects of hydrogen peroxide in neutrophil activation and acute lung injury", Am J Respir Crit Care Med, 179, pp.694~704 (2009)
74. Zmijewski JW, "Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase", J Biol Chem, 285, pp.33154~33164 (2010)
75. O'Neill LA, "Metabolism of inflammation limited by AMPK and pseudo-starvation", Nature, 493, pp.346~355 (2013)
76. Haschemi A, "The sedoheptulose kinase CARKL directs macrophage polarization through control of glucose metabolism", Cell Metab, 15, pp.813~826 (2012)
77. Murray PJ, "Protective and pathogenic functions of macrophage subsets", Nat Rev Immunol, 11, pp.723~737 (2011)
78. Bae HB, "AMP-activated protein kinase enhances the phagocytic ability of macrophages and neutrophils", FASEB J, 25, pp.4358~4368 (2011)
79. Jiang S, "Mitochondria and AMP-activated protein kinase-dependent mechanism of efferocytosis", J Biol Chem, 288, pp.26013~26026 (2013)
80. Sag D, "Adenosine 5'-monophosphate- activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype", J Immunol, 181, pp.8633~8641 (2008)
81. Mounier R, "AMPK α1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration", Cell Metab, 18, pp.251~264 (2013)
82. Rodríguez-Prados JC, "Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation", J Immunol, 185, pp.605~614 (2010)
83. Newsholme P, "Metabolism of glucose, glutamine, long-chain fatty acids and ketone bodies by murine macrophages", Biochem J, 239, pp.121~125 (1986)
84. Krawczyk CM, "Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation", Blood, 115, pp.4742~4749 (2010)
85. Jha AK, "Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization", Immunity, 42, pp.419~430 (2015)
86. Everts B, "Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells", Blood, 120, pp.1422~1431 (2012)
87. Bone NB, "Frontline science: D1 dopaminergic receptor signaling activates the AMPK-bioenergetic pathway in macrophages and alveolar epithelial cells and reduces endotoxin-induced ALI", J Leukoc Biol, 101, pp.357~365 (2017)
88. Mannam P, "Endothelial MKK3 is a critical mediator of lethal murine endotoxemia and acute lung injury", J Immunol, 190, pp.1264~1275 (2013)
89. West AP, "TLR signalling augments macrophage bactericidal activity through mitochondrial ROS", Nature, 472, pp.476~480 (2011)
90. Thomas GD, "The biology of nematode- and IL4Rα -dependent murine macrophage polarization in vivo as defined by RNA-Seq and targeted lipidomics", Blood, 120, pp.e93~e104 (2012)
91. Geissmann F, "Development of monocytes, macrophages, and dendritic cells", Science, 327, pp.656~661 (2010)
92. Wynn TA, "Macrophages in tissue repair, regeneration, and fibrosis", Immunity, 44, pp.450~462 (2016)
93. Duffield JS, "Host responses in tissue repair and fibrosis", Annu Rev Pathol, 8, pp.241~276 (2013)
94. Ganeshan K, "Metabolic regulation of immune responses", Annu Rev Immunol, 32, pp.609~634 (2014)
95. Faist E, "Depression of cellular immunity after major injury. Its association with posttraumatic complications and its reversal with immunomodulation", Arch Surg, 121, pp.1000~1005 (1986)
96. Shelley O, "Interaction between the innate and adaptive immune systems is required to survive sepsis and control inflammation after injury", Shock, 20, pp.123~129 (2003)
97. MacIver NJ, "Metabolic regulation of T lymphocytes", Annu Rev Immunol, 31, pp.259~283 (2013)
98. Rathmell JC, "IL-7 enhances the survival and maintains the size of naive T cells", J Immunol, 167, pp.6869~6876 (2001)
99. Wofford JA, "IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival", Blood, 111, pp.2101~2111 (2008)
100. Barata JT, "Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells", J Exp Med, 200, pp.659~669 (2004)
101. Frauwirth KA, "The CD28 signaling pathway regulates glucose metabolism", Immunity, 16, pp.769~777 (2002)
102. Carr EL, "Glutamine uptake and metabolism are coordinately regulated by ERK", MAPK during T lymphocyte activation, 2010, pp.185, 1037~1044
103. Wang R, "The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation", Immunity, 35, pp.871~882 (2011)
104. Shi LZ, "HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells", J Exp Med, 208, pp.1367~1376 (2011)
105. Michalek RD, "Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets", J Immunol, 186, pp.3299~3303 (2011)
106. Pearce EL, "Enhancing CD8 T-cell memory by modulating fatty acid metabolism", Nature, 460, pp.103~107 (2009)
107. van der Windt GJ, "CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability", Proc Natl Acad Sci USA, 110, pp.14336~14341 (2013)
108. Park J, "Impact of metformin use on lactate kinetics in patients with evere sepsis and septic shock", Shock (2016)
109. Lokhandwala S, "Absolute lactate value vs relative reduction as a predictor of mortality in severe sepsis and septic shock", J Crit Care, 37, pp.179~184 (2017)
110. Varis E, "FINNAKI study group. Evolution of blood lactate and 90-day mortality in septic shock. A post hoc analysis of the Finnaki study", Shock (2016)
111. Puskarich MA, "Lactate clearance in septic shock is not a surrogate for improved microcirculatory flow", Acad Emerg Med, 23, pp.690~693 (2016)
112. Mickiewicz B, "Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality", Am J Respir Crit Care Med, 187, pp.967~976 (2013)
113. Langley RJ, "An integrated clinico-metabolomic model improves prediction of death in sepsis", Sci Transl Med, 5, pp.195~195 (2013)
114. Rogers AJ, "Metabolomic derangements are associated with mortality in critically ill adult patients", PLoS One, 9, pp.e87538~ (2014)
115. Arts RJ, "Cellular metabolism of myeloid cells in sepsis", J Leukoc Biol, 101, pp.151~164 (2017)
116. Yeung F, "Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase", EMBO J, 23, pp.2369~2380 (2004)
117. Zhao X, "Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury", Am J Physiol Lung Cell Mol Physiol, 295, pp.L497~L504 (2008)
118. Park DW, "GSK3 β-dependent inhibition of AMPK potentiates activation of neutrophils and macrophages and enhances severity of acute lung injury", Am J Physiol Lung Cell Mol Physiol, 307, pp.L735~L745 (2014)
119. Tadie JM, "Toll-like receptor 4 engagement inhibits adenosine 5'-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanism", Mol Med, 18, pp.659~668 (2012)
120. Kim J, "Metformin suppresses lipopolysaccharide (LPS)-induced inflammatory response in murine macrophages via activating transcription factor-3 (ATF-3) induction", J Biol Chem, 289, pp.23246~23255 (2014)
121. Escobar DA, "Adenosine monophosphate-activated protein kinase activation protects against sepsis-induced organ injury and inflammation", J Surg Res, 194, pp.262~272 (2015)
122. Yang L, "PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis", Nat Commun, 5, pp.4436~ (2014)
123. Xie M, "PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation", Nat Commun, 7, pp.13280~ (2016)

관련 논문AI추천